| 2026-05-15 |
13G/A |
TNGX / Tango Therapeutics, Inc.
|
|
10,072,225 |
8,000,013 |
|
|
|
| 2026-05-15 |
13G/A |
BJRI / BJ's Restaurants, Inc.
|
|
1,056,946 |
983,280 |
|
|
|
| 2026-05-15 |
13G/A |
QNRX / Quoin Pharmaceuticals, Ltd. - Depositary Receipt (Common Stock)
|
|
2,785,370 |
2,785,370 |
|
|
|
| 2026-05-15 |
13G/A |
ACET / Adicet Bio, Inc.
|
|
625,000 |
313,124 |
|
|
|
| 2026-05-15 |
13G/A |
VSH / Vishay Intertechnology, Inc.
|
|
10,107,022 |
4,952,395 |
|
|
|
| 2026-05-15 |
13G/A |
OM / Outset Medical, Inc.
|
|
1,325,784 |
292,437 |
|
|
|
| 2026-05-15 |
13G/A |
ALGS / Aligos Therapeutics, Inc.
|
|
289,169 |
239,362 |
|
|
|
| 2026-05-15 |
13G |
XOMA / XOMA Royalty Corporation
|
|
|
640,001 |
|
|
|
| 2026-05-15 |
13G |
OKYO / OKYO Pharma Limited
|
|
|
3,652,190 |
|
|
|
| 2026-05-15 |
13G |
BRCB / Black Rock Coffee Bar, Inc.
|
|
|
955,820 |
|
|
|
| 2026-02-17 |
13G/A |
TNGX / Tango Therapeutics, Inc.
|
|
6,029,906 |
10,072,225 |
|
|
|
| 2026-02-17 |
13G/A |
PLRX / Pliant Therapeutics, Inc.
|
|
4,504,817 |
2,026,191 |
|
|
|
| 2026-02-17 |
13G/A |
ALGS / Aligos Therapeutics, Inc.
|
|
468,199 |
289,169 |
|
|
|
| 2026-02-17 |
13G |
ACET / Adicet Bio, Inc.
|
|
|
625,000 |
|
|
|
| 2026-02-17 |
13G |
BJRI / BJ's Restaurants, Inc.
|
|
|
1,056,946 |
|
|
|
| 2026-02-17 |
13G/A |
VSH / Vishay Intertechnology, Inc.
|
|
6,813,765 |
10,107,022 |
|
|
|
| 2026-02-17 |
13G |
QNRX / Quoin Pharmaceuticals, Ltd. - Depositary Receipt (Common Stock)
|
|
|
2,785,370 |
|
|
|
| 2025-11-14 |
13G |
SABS / SAB Biotherapeutics, Inc.
|
|
|
7,125,881 |
|
|
|
| 2025-11-14 |
13G |
EQ / Equillium, Inc.
|
|
|
3,508,771 |
|
|
|
| 2025-11-14 |
13G |
VSH / Vishay Intertechnology, Inc.
|
|
|
6,813,765 |
|
|
|
| 2025-11-14 |
13G |
PLRX / Pliant Therapeutics, Inc.
|
|
|
4,504,817 |
|
|
|
| 2025-11-14 |
13G/A |
AIRO / AIRO Group Holdings, Inc.
|
|
1,952,611 |
2,753,067 |
|
|
|
| 2025-11-14 |
13G/A |
SGMT / Sagimet Biosciences Inc.
|
|
2,552,536 |
1,501,357 |
|
|
|
| 2025-11-14 |
13G/A |
ZVRA / Zevra Therapeutics, Inc.
|
|
4,048,653 |
3,476,143 |
|
|
|
| 2025-11-14 |
13G/A |
ALGS / Aligos Therapeutics, Inc.
|
|
518,300 |
468,199 |
|
|
|
| 2025-08-14 |
13G |
SGMT / Sagimet Biosciences Inc.
|
|
|
2,552,536 |
|
|
|
| 2025-08-14 |
13G/A |
TNYA / Tenaya Therapeutics, Inc.
|
|
5,916,167 |
9,000,000 |
|
|
|
| 2025-08-14 |
13G |
TNGX / Tango Therapeutics, Inc.
|
|
|
6,029,906 |
|
|
|
| 2025-08-14 |
13G |
AIRO / AIRO Group Holdings, Inc.
|
|
|
1,952,611 |
|
|
|
| 2025-08-14 |
13G/A |
ALGS / Aligos Therapeutics, Inc.
|
|
315,383 |
518,300 |
|
|
|
| 2025-05-15 |
13G |
ALGS / Aligos Therapeutics, Inc.
|
|
|
315,383 |
|
|
|
| 2025-05-15 |
13G |
TNYA / Tenaya Therapeutics, Inc.
|
|
|
5,916,167 |
|
|
|
| 2025-05-15 |
13G |
OM / Outset Medical, Inc.
|
|
|
1,325,784 |
|
|
|
| 2025-02-14 |
13G/A |
TVTX / Travere Therapeutics, Inc.
|
|
4,340,340 |
2,114,056 |
|
|
|
| 2025-02-14 |
13G/A |
GRDN / Guardian Pharmacy Services, Inc.
|
|
568,131 |
415,120 |
|
|
|
| 2025-02-14 |
13G/A |
TARA / Protara Therapeutics, Inc.
|
|
1,576,567 |
1,331,258 |
|
|
|
| 2024-11-14 |
13G |
GRDN / Guardian Pharmacy Services, Inc.
|
|
|
568,131 |
|
|
|
| 2024-11-14 |
13G |
TVTX / Travere Therapeutics, Inc.
|
|
|
4,340,340 |
|
|
|
| 2024-11-14 |
13G |
ZVRA / Zevra Therapeutics, Inc.
|
|
|
4,048,653 |
|
|
|
| 2024-11-14 |
13G |
TARA / Protara Therapeutics, Inc.
|
|
|
1,576,567 |
|
|
|
| 2024-02-12 |
13G |
VERA / Vera Therapeutics, Inc.
|
|
|
1,140,632 |
|
|
|
| 2024-02-12 |
13G/A |
CLDI / Calidi Biotherapeutics, Inc.
|
|
400,000 |
125,000 |
|
|
|
| 2024-02-12 |
13G/A |
US6710051060 / OPY Acquisition Corp. I
|
|
200,000 |
0 |
|
|
|
| 2023-02-10 |
13G/A |
SNTI / Senti Biosciences Holdings, Inc.
|
|
|
0 |
|
|
|
| 2023-02-10 |
13G |
US6710051060 / OPY Acquisition Corp. I
|
|
|
200,000 |
|
|
|
| 2023-02-10 |
13G/A |
ACDI / Ascendant Digital Acquisition Corp III - Class A
|
|
1,912,500 |
1,286,000 |
|
|
|
| 2023-02-10 |
13G/A |
CLDI / Calidi Biotherapeutics, Inc.
|
|
1,980,000 |
400,000 |
|
|
|
| 2022-02-11 |
13G |
DYNS / Dynamics Special Purpose Corp Class A
|
|
|
2,000,000 |
|
|
|
| 2022-02-11 |
13G |
ACDI / Ascendant Digital Acquisition Corp III - Class A
|
|
|
1,912,500 |
|
|
|
| 2022-02-11 |
13G |
CLDI / Calidi Biotherapeutics, Inc.
|
|
|
1,980,000 |
|
|
|
| 2022-02-11 |
13G/A |
MKTW / MarketWise, Inc.
|
|
|
0 |
|
|
|
| 2022-02-11 |
13G/A |
ELDN / Eledon Pharmaceuticals, Inc.
|
|
|
685,273 |
|
|
|
| 2021-02-16 |
13G/A |
MKTW / MarketWise, Inc.
|
|
|
4,008,770 |
|
|
|
| 2021-02-16 |
13G |
88907J107 / Novus Therapeutics, Inc.
|
|
|
814,756 |
|
|
|